This study evaluated the effects of a combination investigational therapy compared to a placebo when used in addition to your current statin therapy.

The total study participation was approximately 18 weeks.

Qualified participants:

  • Generally healthy; 18-75 years of age
  • Had elevated LDL cholesterol
  • Were on a stable doses of high-intensity statin (atorvastatin 40 or 80 mg or rosuvastatin 20 or 40 mg)

Stay on track with clinical trials you can trust.

Get in touch with us today and subscribe to our newsletter to see how we can provide the clinical trial and scientific consulting services you need.